The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

The biopharma company said it filled the newly created role of chief operating officer to lead its commercial strategy, ...

Emcure Pharmaceuticals, Honasa Consumers, and Reliance Home Finance will be among 164 companies to post earnings reports for the January-March quarter on May 22 ...

Analysts believe that recent product launches in India will further solidify Sun Pharmas leading position in the branded ...

Notably, the companys EBITDA surged by 16.5 percent, increasing from Rs 586.3 crore to Rs 683.2 crore from previous year.

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Cumberland Pharmaceuticals' CEO discusses how potential tariffs on drugs could affect the Nashville-based company's business.

Having posted record annual revenue of $NZ208 million, AFT Pharmaceuticals says it can achieve further 50% growth over the ...

BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and ...

Gulf South Angels, a New Orleans-based investment network, is investing in non-opioid pain drug startup South Rampart Pharma, ...

Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as ...

One of Mission’s largest employers announced mass layoffs in the company, citing financial concerns and a “challenging environment.” ...